Insomnia

FDA pushes Merck's suvorexant aside

By

The regulator says Merck needs to focus on lower doses of the drug.

Finding opportunity in FDA focus on drugged driving

Finding opportunity in FDA focus on drugged driving

By

With its recent actions on sleep aids and allergy medications, the FDA is demonstrating growing concern about the effects of prescription drugs on driving. One CRO is fielding a fleet of driving simulators to help manufacturers salve the agency's worries.

Email Newsletters